High Mark Wealth Management LLC Mirum Pharmaceuticals, Inc. Transaction History
High Mark Wealth Management LLC
- $173 Million
- Q4 2024
A detailed history of High Mark Wealth Management LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 180 shares of MIRM stock, worth $9,007. This represents 0.0% of its overall portfolio holdings.
Number of Shares
180
Previous 180
-0.0%
Holding current value
$9,007
Previous $7,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MIRM
# of Institutions
210Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$329 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$229 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$162 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$140 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$130 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.84B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...